ND MEDICAL TECHNOLOGY LIMITED reduced its holdings in CH FRONTIER TEC (01661) by 1.992 million shares at an approximate price of HKD 1.67 per share.
On July 17, ND MEDICAL TECHNOLOGY LIMITED reduced its stake in China Frontier Technology Group (01661) by 1,992,000 shares, at a price of HKD 1.6737 per share, for a total amount of approximately HKD 3.334 million.
According to the latest data from the Hong Kong Stock Exchange, on July 17, ND MEDICAL TECHNOLOGY LIMITED reduced its holdings in CH FRONTIER TEC (01661) by 1,992,000 shares, at a price of HKD 1.6737 per share, for a total amount of approximately HKD 3.334 million. After the reduction, the latest number of shares held is 17,026,000, with a current ownership ratio of 8.95%.
This transaction involves other related parties: Wu Meizhen.
Related Articles
GAPACK (00468) recommends adopting a restricted share unit plan.
WELLCELL HOLD (02477) issues profit warning, expecting a mid-term net loss attributable to shareholders not exceeding approximately 45 million yuan, turning from profit to loss year-on-year.
TAN ZHIXIN has been appointed as the Joint Company Secretary and Authorized Representative.
GAPACK (00468) recommends adopting a restricted share unit plan.
WELLCELL HOLD (02477) issues profit warning, expecting a mid-term net loss attributable to shareholders not exceeding approximately 45 million yuan, turning from profit to loss year-on-year.
TAN ZHIXIN has been appointed as the Joint Company Secretary and Authorized Representative.
RECOMMEND
